Olab

OLAB Bioscience is an industrial biotechnology company that leverages artificial intelligence and advanced algorithms to optimize synthetic biology workflows. The company focuses on the Ideation-Design-Build-Test-Learn (IDBTL) process to streamline the development of microbial strains for industrial fermentation and commercial production. Through strategic partnerships, such as its collaboration with CJ BIO, OLAB Bioscience applies its digital platform to create scalable and automated strain development pipelines. Additionally, the company is engaged in the development of next-generation microbiome therapeutics, utilizing synthetic biology and metabolic engineering to target the human gut microbiota for disease prevention and treatment.